| Literature DB >> 3190999 |
P Koskinen1, V Manninen, A Eisalo.
Abstract
To assess the effects of angiotensin-converting enzyme inhibition with quinapril on blood lipid profile, serum total cholesterol and triglycerides, together with high-density and low-density lipoprotein cholesterol were analysed in 23 hypertensive patients receiving either placebo (7 patients) or quinapril hydrochloride (16 patients). After 12 weeks of therapy there were no significant changes in blood lipids in either group. No unfavourable changes in blood lipid profile were observed even after 1 year of therapy with quinapril hydrochloride in 13 patients.Entities:
Mesh:
Substances:
Year: 1988 PMID: 3190999 PMCID: PMC1386572 DOI: 10.1111/j.1365-2125.1988.tb03409.x
Source DB: PubMed Journal: Br J Clin Pharmacol ISSN: 0306-5251 Impact factor: 4.335